Celldex Therapeutics (CLDX) Tops Q2 Loss Views by 2c/Share
Tweet Send to a Friend
Celldex Therapeutics (NASDAQ: CLDX) reported Q2 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Celldex Therapeutics (CLDX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Celldex Therapeutics (CLDX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- UPDATE: Sears Holding Corp. (SHLD) Reports Q1 Loss of $1.29
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
